Company news

Exagen Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Exagen Inc. Announces $27.2 Million Debt Refinancing

October 24, 2021

Exagen Showcases Eight Scientific Presentations at ACR’s Virtual Annual Meeting in November 2021

October 20, 2021

Exagen Inc. to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

September 12, 2021

Exagen Inc. Reports Second Quarter 2021 Results

August 8, 2021

Exagen Appoints Ana Hooker to Board of Directors

July 29, 2021

Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth Conference

July 28, 2021

Exagen to Announce Second Quarter 2021 Financial Results on August 9, 2021

July 25, 2021

Exagen Elects Frank Stokes to Board of Directors

June 17, 2021

Exagen Inc. Reports First Quarter 2021 Results

May 10, 2021

Exagen Inc., Allegheny Health Network Research Institute and AHN Autoimmunity Institute Announce Collaboration to Develop Novel Patented Biomarkers into Clinical Diagnostic Tests

May 3, 2021

Exagen Announces New Campaign and Initiatives for Lupus Awareness Month

May 2, 2021

Exagen to Announce First Quarter 2021 Financial Results on May 11, 2021

April 26, 2021

Exagen Inc. Announces Study on the Long-Term Effects of COVID-19 Infection in the Development of Autoimmune Diseases

March 28, 2021

Exagen Inc. Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

March 24, 2021

Exagen Inc. Announces Pricing of Public Offering of Common Stock

March 21, 2021

Exagen Inc. Reports Fourth Quarter and Full Year 2020 Results

March 15, 2021

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 16, 2021

March 1, 2021

Exagen Inc. Partners with Boston’s Tufts Medical Center to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases

January 20, 2021

Exagen Inc. Reports Preliminary Fourth Quarter 2020 Testing Results

January 9, 2021

Exagen Inc. Partners with Oregon’s St. Charles Health System to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases

January 3, 2021

Exagen Inc. Reports Third Quarter 2020 Results

November 9, 2020

Exagen Inc. Announces Study to Evaluate Emergence of Autoimmune Diseases After COVID-19 Infection

November 1, 2020

Exagen to Announce Third Quarter Financial Results on November 10, 2020

October 26, 2020

Exagen Inc. Announces Agreement with Provider Network of America Expanding Access for AVISE® Tests to 8 Million Members

September 28, 2020

Exagen Appoints Wendy Johnson to Board of Directors

September 22, 2020

Exagen Launches Test to Aid in the Detection of ANCA-Associated Vasculitis (AAV)

September 20, 2020

Exagen Inc. Announces a Collaboration with Hospital for Special Surgery (HSS) for Antiphospholipid Syndrome

August 2, 2020

Exagen Inc. Reports Second Quarter 2020 Results

July 27, 2020

Exagen Inc. AVISE Testing Now Covered and In-Network with TRICARE East

July 26, 2020

Exagen to Announce Second Quarter Financial Results on July 28, 2020

July 15, 2020

Exagen and the Ohio State Innovation Foundation Announce Exclusive License Agreement and Research Collaboration for a Novel, Rule-In, Blood Test to Support the Diagnosis of Fibromyalgia

June 16, 2020

Exagen Inc. Announces Clinical Trial Conducted at Major Academic Center in Distinguishing Type 1 and Type 2 Lupus

June 2, 2020

Exagen Inc. Reports First Quarter 2020 Results

May 10, 2020

Exagen to Announce First Quarter Financial Results on May 11, 2020

April 26, 2020

Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results

March 24, 2020

Exagen Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer, and Anja Kammesheidt, Ph.D., as Chief Scientific Officer

March 23, 2020

Exagen Inc. Partners with Sonora Quest Laboratories to Offer AVISE Testing for Patients Suspected of Autoimmune Disease

March 15, 2020

Exagen to Announce Fourth Quarter and Year-End 2019 Financial Results on March 25, 2020

March 10, 2020

Exagen Announces Addition to Russell 3000® and 2000® Indexes

December 15, 2019

Exagen extends agreement with GSK for a third year to drive greater awareness about challenges facing lupus diagnosis and management

November 21, 2019

Exagen Inc. Announces $26.2 Million Debt Refinancing

November 20, 2019

Exagen Inc. Reports Third Quarter 2019 Results

November 11, 2019

Exagen to Announce Third Quarter 2019 Financial Results on November 12th, 2019

October 28, 2019

Exagen Announces Publication of Two Key Studies Validating Clinical Performance of AVISE® Lupus in Patients with Probable SLE and Demonstrating Superior Clinical Utility Compared to Standard Diagnostic Testing

October 14, 2019

Exagen Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

September 22, 2019

← Newer news releases

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 6 decks. Every deck is listed under its year.